HIV-associated nephropathy: epidemiology, pathogenesis, diagnosis and management

References

• Gardenswartz MH, Lerner CW, Seligson GR et al. Renal disease in patients with AIDS: a clinicopathologic study. Clin. Nephrol.21(4), 197–204 (1984).
   PubMed Web of Science ®Google Scholar
• Pardo V, Aldana M, Colton RM et al. Glomerular lesions in the acquired immunodeficiency syndrome. Ann. Intern. Med.101(4), 429–434 (1984).
   PubMed Web of Science ®Google Scholar
• Rao TK, Filippone EJ, Nicastri AD et al. Associated focal and segmental glomerulosclerosis in the acquired immunodeficiency syndrome. N. Engl. J. Med.310(11), 669–673 (1984).
   PubMed Web of Science ®Google Scholar
• Winston JA, Bruggeman LA, Ross MD et al. Nephropathy and establishment of a renal reservoir of HIV type 1 during primary infection. N. Engl. J. Med.344(26), 1979–1984 (2001).
   PubMed Web of Science ®Google Scholar
• Winston JA, Klotman ME, Klotman PE. HIV-associated nephropathy is a late, not early, manifestation of HIV-1 infection. Kidney Int.55(3), 1036–1040 (1999).
   PubMed Web of Science ®Google Scholar
• Lucas GM, Eustace JA, Sozio S, Mentari EK, Appiah KA, Moore RD. Highly active antiretroviral therapy and the incidence of HIV-1-associated nephropathy: a 12-year cohort study. AIDS18(3), 541–546 (2004).
   PubMed Web of Science ®Google Scholar
• Carbone L, D’Agati V, Cheng JT, Appel GB. Course and prognosis of human immunodeficiency virus-associated nephropathy. Am. J. Med.87(4), 389–395 (1989).
   PubMed Web of Science ®Google Scholar
• Cantor ES, Kimmel PL, Bosch JP. Effect of race on expression of acquired immunodeficiency syndrome-associated nephropathy. Arch. Intern. Med.151(1), 125–128 (1991).
   PubMedGoogle Scholar
• Laradi A, Mallet A, Beaufils H, Allouache M, Martinez F. HIV-associated nephropathy: outcome and prognosis factors. Groupe d’ Etudes Nephrologiques d’Ile de France. J. Am. Soc. Nephrol.9(12), 2327–2335 (1998).
   PubMed Web of Science ®Google Scholar
• Williams DI, Williams DJ, Williams IG, Unwin RJ, Griffiths MH, Miller RF. Presentation, pathology, and outcome of HIV associated renal disease in a specialist centre for HIV/AIDS. Sex Transm. Infect.74(3), 179–184 (1998).
   PubMed Web of Science ®Google Scholar
• Abbott KC, Hypolite I, Welch PG, Agodoa LY. Human immunodeficiency virus/acquired immunodeficiency syndrome-associated nephropathy at end-stage renal disease in the United States: patient characteristics and survival in the pre highly active antiretroviral therapy era. J. Nephrol.14(5), 377–383 (2001).
   PubMed Web of Science ®Google Scholar
• Kopp JB, Winkler C. HIV-associated nephropathy in African Americans. Kidney Int.83(Suppl.), S43–S49 (2003).
   Google Scholar
• Eggers PW, Kimmel PL. Is there an epidemic of HIV Infection in the US ESRD program? J. Am. Soc. Nephrol.15(9), 2477–2485 (2004).
   PubMed Web of Science ®Google Scholar
• Shahinian V, Rajaraman S, Borucki M, Grady J, Hollander WM, Ahuja TS. Prevalence of HIV-associated nephropathy in autopsies of HIV-infected patients. Am. J. Kidney. Dis.35(5), 884–888 (2000).
   PubMed Web of Science ®Google Scholar
• Mazbar SA, Schoenfeld PY, Humphreys MH. Renal involvement in patients infected with HIV: experience at San Francisco General Hospital. Kidney Int.37(5), 1325–1332 (1990).
   PubMed Web of Science ®Google Scholar
• Viertel A, Weidmann E, Rickerts V, Scheuermann EH, Geiger H, Brodt H. Renal involvement in HIV-infection. Results from the Frankfurt AIDS Cohort Study (FACS) and a review of the literature. Eur. J. Med. Res.5(5), 185–198 (2000).
   PubMedGoogle Scholar
• Hailemariam S, Walder M, Burger HR et al. Renal pathology and premortem clinical presentation of Caucasian patients with AIDS: an autopsy study from the era prior to antiretroviral therapy. Swiss Med. Wkly131(27–28), 412–417 (2001).
   PubMed Web of Science ®Google Scholar
• Nochy D, Glotz D, Dosquet P et al. Renal disease associated with HIV infection: a multicentric study of 60 patients from Paris hospitals. Nephrol. Dial. Transplant8(1), 11–19 (1993).
   PubMed Web of Science ®Google Scholar
• Nochy D, Glotz D, Dosquet P et al. Renal lesions associated with human immunodeficiency virus infection: North American vs. European experience. Adv. Nephrol. Necker. Hosp.22, 269–286 (1993).
   PubMedGoogle Scholar
• Ross MJ, Klotman PE. Recent progress in HIV-associated nephropathy. J. Am. Soc. Nephrol.13(12), 2997–3004 (2002).
   PubMed Web of Science ®Google Scholar
• Lucas GM, Mehta SH, Atta MG et al. End-stage renal disease and chronic kidney disease in a cohort of African–American HIV-infected and at-risk HIV-seronegative participants followed between 1988 and 2004. AIDS21(18), 2435–2443 (2007).
   PubMed Web of Science ®Google Scholar
• Han TM, Naicker S, Ramdial PK, Assounga AG. A cross-sectional study of HIV-seropositive patients with varying degrees of proteinuria in South Africa. Kidney. Int.69(12), 2243–2250 (2006).
   PubMed Web of Science ®Google Scholar
• Szabo S, James CW, Telford G. Unusual presentations of primary human immunodeficiency virus infection. AIDS Patient Care STDS16(6), 251–254 (2002).
   PubMed Web of Science ®Google Scholar
• Izzedine H, Wirden M, Launay-Vacher V. Viral load and HIV-associated nephropathy. N. Engl. J. Med.353(10), 1072–1074 (2005).
   PubMedGoogle Scholar
• Dickie P, Felser J, Eckhaus M et al. HIV-associated nephropathy in transgenic mice expressing HIV-1 genes. Virology185(1), 109–119 (1991).
   PubMed Web of Science ®Google Scholar
• Hanna Z, Kay DG, Cool M, Jothy S, Rebai N, Jolicoeur P. Transgenic mice expressing human immunodeficiency virus type 1 in immune cells develop a severe AIDS-like disease. J. Virol.72(1), 121–132 (1998).
   PubMed Web of Science ®Google Scholar
• Hanna Z, Kay DG, Rebai N, Guimond A, Jothy S, Jolicoeur P. Nef harbors a major determinant of pathogenicity for an AIDS-like disease induced by HIV-1 in transgenic mice. Cell95(2), 163–175 (1998).
   PubMed Web of Science ®Google Scholar
• Zhong J, Zuo Y, Ma J et al. Expression of HIV-1 genes in podocytes alone can lead to the full spectrum of HIV-1-associated nephropathy. Kidney Int.68(3), 1048–1060 (2005).
   PubMed Web of Science ®Google Scholar
• Bruggeman LA, Ross MD, Tanji N et al. Renal epithelium is a previously unrecognized site of HIV-1 infection. J. Am. Soc. Nephrol.11(11), 2079–2087 (2000).
   PubMed Web of Science ®Google Scholar
• Marras D, Bruggeman LA, Gao F et al. Replication and compartmentalization of HIV-1 in kidney epithelium of patients with HIV-associated nephropathy. Nat. Med.8(5), 522–526 (2002).
   PubMed Web of Science ®Google Scholar
• Barisoni L, Mokrzycki M, Sablay L, Nagata M, Yamase H, Mundel P. Podocyte cell cycle regulation and proliferation in collapsing glomerulopathies. Kidney Int.58(1), 137–143 (2000).
   PubMed Web of Science ®Google Scholar
• Albaqumi M, Soos TJ, Barisoni L, Nelson PJ. Collapsing glomerulopathy. J. Am. Soc. Nephrol.17(10), 2854–2863 (2006).
   PubMed Web of Science ®Google Scholar
• Wali RK, Drachenberg CI, Papadimitriou JC, Keay S, Ramos E. HIV-1-associated nephropathy and response to highly-active antiretroviral therapy. Lancet352(9130), 783–784 (1998).
   PubMed Web of Science ®Google Scholar
• Atta MG, Gallant JE, Rahman MH et al. Antiretroviral therapy in the treatment of HIV-associated nephropathy. Nephrol. Dial. Transplant.21(10), 2809–2813 (2006).
   PubMed Web of Science ®Google Scholar
• Scialla JJ, Atta MG, Fine DM. Relapse of HIV-associated nephropathy after discontinuing highly active antiretroviral therapy. AIDS (London, England),21(2), 263–264 (2007).
   PubMed Web of Science ®Google Scholar
• Freedman BI, Soucie JM, Stone SM, Pegram S. Familial clustering of end-stage renal disease in blacks with HIV-associated nephropathy. Am. J. Kidney Dis.34(2), 254–258 (1999).
   PubMed Web of Science ®Google Scholar
• Gharavi AG, Ahmad T, Wong RD et al. Mapping a locus for susceptibility to HIV-1-associated nephropathy to mouse chromosome 3. Proc. Natl Acad. Sci. USA101(8), 2488–2493 (2004).
   PubMed Web of Science ®Google Scholar
• Ross MJ, Klotman PE, Winston JA. HIV-associated nephropathy: case study and review of the literature. AIDS Patient Care STDS14(12), 637–645 (2000).
   PubMed Web of Science ®Google Scholar
• Berliner AR, Fine DM, Lucas GM et al. Observations on a cohort of HIV-infected patients undergoing native renal biopsy. Am. J. Nephrol.28(3), 478–486 (2008).
   PubMed Web of Science ®Google Scholar
• D’Agati V, Suh JI, Carbone L, Cheng JT, Appel G. Pathology of HIV-associated nephropathy: a detailed morphologic and comparative study. Kidney Int.35(6), 1358–1370 (1989).
   PubMed Web of Science ®Google Scholar
• Atta M, Fine D, Kirk G, Mehta S, Moore R, Lucas G. Survival during renal replacement therapy among African Americans infected with HIV type 1 in urban Baltimore, Maryland. Clin. Infect. Dis.45(12), 1625–1632 (2007).
   PubMed Web of Science ®Google Scholar
• Atta MG, Longenecker JC, Fine DM et al. Sonography as a predictor of human immunodeficiency virus-associated nephropathy. J. Ultrasound Med.23(5), 603–610 (2004).
   PubMed Web of Science ®Google Scholar
• Atta MG, Choi MJ, Longenecker JC et al. Nephrotic range proteinuria and CD4 count as noninvasive indicators of HIV-associated nephropathy. Am. J. Med.118(11), 1288.e1221–1288.e1226 (2005).
   Google Scholar
• Estrella M, Fine DM, Gallant JE et al. HIV type 1 RNA level as a clinical indicator of renal pathology in HIV-infected patients. Clin. Infect. Dis.43(3), 377–380 (2006).
   PubMed Web of Science ®Google Scholar
• Ross MJ, Fan C, Ross MD et al. HIV-1 infection initiates an inflammatory cascade in human renal tubular epithelial cells. J. Acquir. Immune Defic. Syndr.42(1), 1–11 (2006).
   PubMed Web of Science ®Google Scholar
• Briggs WA, Tanawattanacharoen S, Choi MJ, Scheel PJ Jr, Nadasdy T, Racusen L. Clinicopathologic correlates of prednisone treatment of human immunodeficiency virus-associated nephropathy. Am. J. Kidney Dis.28(4), 618–621 (1996).
   PubMed Web of Science ®Google Scholar
• Smith MC, Austen JL, Carey JT et al. Prednisone improves renal function and proteinuria in human immunodeficiency virus-associated nephropathy. Am. J. Med.101(1), 41–48 (1996).
   PubMed Web of Science ®Google Scholar
• Eustace JA, Nuermberger E, Choi M, Scheel PJ Jr, Moore R, Briggs WA. Cohort study of the treatment of severe HIV-associated nephropathy with corticosteroids. Kidney Int.58(3), 1253–1260 (2000).
   PubMed Web of Science ®Google Scholar
• Martos A, Podzamczer D, Martinez-Lacasa J, Rufi G, Santin M, Gudiol F. Steroids do not enhance the risk of developing tuberculosis or other AIDS-related diseases in HIV-infected patients treated for Pneumocystis carinii pneumonia. AIDS9(9), 1037–1041 (1995).
   PubMed Web of Science ®Google Scholar
• Gallant JE, Chaisson RE, Moore RD. The effect of adjunctive corticosteroids for the treatment of Pneumocystis carinii pneumonia on mortality and subsequent complications. Chest114(5), 1258–1263 (1998).
   PubMed Web of Science ®Google Scholar
• Burns GC, Matute R, Onyema D, Davis I, Toth I. Response to inhibition of angiotensin-converting enzyme in human immunodeficiency virus-associated nephropathy: a case report. Am. J. Kidney Dis.23(3), 441–443 (1994).
   PubMed Web of Science ®Google Scholar
• Kimmel PL, Mishkin GJ, Umana WO. Captopril and renal survival in patients with human immunodeficiency virus nephropathy. Am. J. Kidney Dis.28(2), 202–208 (1996).
   PubMed Web of Science ®Google Scholar
• Burns GC, Paul SK, Toth IR, Sivak SL. Effect of angiotensin-converting enzyme inhibition in HIV-associated nephropathy. J. Am. Soc. Nephrol.8(7), 1140–1146 (1997).
   PubMed Web of Science ®Google Scholar
• Wei A, Burns GC, Williams BA, Mohammed NB, Visintainer P, Sivak SL. Long-term renal survival in HIV-associated nephropathy with angiotensin-converting enzyme inhibition. Kidney Int.64(4), 1462–1471 (2003).
   PubMed Web of Science ®Google Scholar
• Ortiz C, Meneses R, Jaffe D, Fernandez JA, Perez G, Bourgoignie JJ. Outcome of patients with human immunodeficiency virus on maintenance hemodialysis. Kidney Int.34(2), 248–253 (1988).
   PubMed Web of Science ®Google Scholar
• Tebben JA, Rigsby MO, Selwyn PA, Brennan N, Kliger A, Finkelstein FO. Outcome of HIV infected patients on continuous ambulatory peritoneal dialysis. Kidney Int.44(1), 191–198 (1993).
   PubMed Web of Science ®Google Scholar
• Ahuja TS, Grady J, Khan S. Changing trends in the survival of dialysis patients with human immunodeficiency virus in the United States. J. Am. Soc. Nephrol.13(7), 1889–1893 (2002).
   PubMed Web of Science ®Google Scholar
• Macrae J, Friedman AL, Eggers P, Friedman EA. Improved survival in HIV-infected African–Americans with ESRD. Clin. Nephrol.64(2), 124–128 (2005).
   PubMed Web of Science ®Google Scholar
• US Renal Data System. USRDS 2006 Annual Data Report: Reference Tables of End-stage Renal Disease in the United States. National Institutes of Health, National Institute of Diabetes and Digestive Diseases and Kidney Diseases. Bethesda, MD, USA (2006).
   Google Scholar
• Srivastava T, Garola RE, Singh HK. Cell-cycle regulatory proteins in the podocyte in collapsing glomerulopathy in children. Kidney Int.70(3), 529–535 (2006).
   PubMed Web of Science ®Google Scholar
• He JC, Lu TC, Fleet M et al. Retinoic acid inhibits HIV-1-induced podocyte proliferation through the cAMP pathway. J. Am. Soc. Nephrol.18(1), 93–102 (2007).
   PubMed Web of Science ®Google Scholar
• Ahuja TS, Borucki M, Funtanilla M, Shahinian V, Hollander M, Rajaraman S. Is the prevalence of HIV-associated nephropathy decreasing? Am. J. Nephrol.19(6), 655–659 (1999).
   PubMed Web of Science ®Google Scholar